RESMED INC — Director's Dealing 2020

Nov 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-11-17

Reporting Person: Hollingshead James (President, Sleep Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-17	ResMed Common Stock	A	26246	$214.74	Acquired	108680	Direct
2020-11-17	ResMed Common Stock	F	15547	$214.74	Disposed	93133	Direct

Footnotes

F1: Represents performance-based restricted stock units granted on November 16, 2017. The shares were earned on November 17, 2020, when the compensation committee certified that the performance metrics were met.

F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017.